Chemoradiation therapy

COMBINATION_PRODUCT3 trials

Sponsors

Shandong Cancer Hospital and Institute, Women's Hospital School Of Medicine Zhejiang University, Memorial Sloan Kettering Cancer Center

Conditions

Endometrial Cancer Stage IEndometrial Cancer Stage IIGlioblastomaHead and Neck CancerHead and Neck CarcinomaHead and Neck NeoplasmsHead and Neck Squamous Cell Carcinoma

Phase 2

A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer

RecruitingNCT05544136

Memorial Sloan Kettering Cancer CenterHead and Neck Cancer, Head and Neck Carcinoma, Head and Neck Neoplasms +1

Start: 2022-09-12End: 2027-03-12Target: 12Updated: 2026-08-12

Unknown Phase

A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma

Shandong Cancer Hospital and InstituteGlioblastoma

Start: 2013-08-31End: 2016-09-30Updated: 2016-01-21

PROfiling Based Endometrial Cancer Adjuvant Therapy

RecruitingNCT05179447

Women's Hospital School Of Medicine Zhejiang UniversityEndometrial Cancer Stage I, Endometrial Cancer Stage II

Start: 2022-01-24End: 2027-01-01Target: 590Updated: 2025-04-01

Related Papers

Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT)

Journal of Gynecologic Oncology2023-01-017 citations